Ptc Therapeutics (PTCT) Invested Capital (2016 - 2025)
Historic Invested Capital for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to -$139.2 million.
- Ptc Therapeutics' Invested Capital rose 8656.07% to -$139.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$139.2 million, marking a year-over-year increase of 8656.07%. This contributed to the annual value of -$1.1 billion for FY2024, which is 3521.25% down from last year.
- Ptc Therapeutics' Invested Capital amounted to -$139.2 million in Q3 2025, which was up 8656.07% from -$187.4 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Invested Capital ranged from a high of $325.7 million in Q1 2021 and a low of -$1.1 billion during Q4 2024
- Its 5-year average for Invested Capital is -$349.3 million, with a median of -$205.6 million in 2022.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 52526.02% in 2023, then surged by 8656.07% in 2025.
- Quarter analysis of 5 years shows Ptc Therapeutics' Invested Capital stood at $151.0 million in 2021, then crashed by 282.1% to -$274.9 million in 2022, then plummeted by 190.38% to -$798.4 million in 2023, then tumbled by 35.21% to -$1.1 billion in 2024, then skyrocketed by 87.1% to -$139.2 million in 2025.
- Its last three reported values are -$139.2 million in Q3 2025, -$187.4 million for Q2 2025, and -$166.9 million during Q1 2025.